Veeva Systems (VEEV) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Veeva is expected to report Q2 fiscal 2027 results on August 26 after the market closes, with analysts forecasting $2.22 in earnings per share and $905.4 million in revenue. The company’s Q2 EPS guidance is $2.21–$2.22.
• The company’s latest quarter exceeded expectations, posting $2.24 EPS versus $2.14 expected and $882.95 million in revenue versus $857.73 million forecast; revenue increased 16.3% year over year.
• Analyst sentiment is broadly positive, with a “Moderate Buy” consensus and average price target of $253.75, though insider Thomas Schwenger sold $9 million of shares under a pre-arranged trading plan. Institutional investors own approximately 88.2% of the stock.

Veeva Systems (NYSE:VEEV - Get Free Report) is anticipated to announce its Q2 2027 results after the market closes on Wednesday, August 26th. Analysts expect Veeva Systems to announce earnings of $2.22 per share and revenue of $905.3850 million for the quarter. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Investors are encouraged to explore the company's upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Wednesday, August 26, 2026 at 5:00 PM ET.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. The business had revenue of $882.95 million during the quarter, compared to analysts' expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business's revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.97 earnings per share. On average, analysts expect Veeva Systems to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Veeva Systems Price Performance

NYSE VEEV opened at $243.33 on Wednesday. The stock's 50 day simple moving average is $192.90 and its 200-day simple moving average is $180.87. The company has a market cap of $39.53 billion, a PE ratio of 43.37, a price-to-earnings-growth ratio of 1.05 and a beta of 0.92. Veeva Systems has a 1-year low of $148.05 and a 1-year high of $310.50.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Needham & Company LLC restated a "buy" rating and issued a $270.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. The Goldman Sachs Group dropped their target price on shares of Veeva Systems from $190.00 to $165.00 and set a "sell" rating for the company in a report on Thursday, June 4th. BNP Paribas Exane reiterated an "outperform" rating and issued a $285.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Canaccord Genuity Group reduced their target price on shares of Veeva Systems from $235.00 to $220.00 and set a "hold" rating for the company in a research report on Thursday, June 4th. Finally, Guggenheim initiated coverage on shares of Veeva Systems in a research note on Thursday, July 23rd. They issued a "buy" rating and a $232.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $253.75.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Analyst price targets raised: Barclays lifted its target from $235 to $275 and assigned an “overweight” rating. Oppenheimer raised its target from $225 to $300 with an “outperform” rating, while Stifel increased its target from $230 to $275 and issued a “buy” rating. These upgrades indicate improving confidence in Veeva’s growth prospects. Benzinga analyst price-target reports
• Positive Sentiment: Solid operating momentum: Veeva’s latest quarterly results exceeded consensus estimates, with earnings per share of $2.24 versus $2.14 expected and revenue of $882.95 million versus $857.73 million expected. Revenue grew 16.3% year over year, and management provided fiscal 2027 earnings guidance. Veeva Systems financial and earnings information
• Positive Sentiment: Institutional support: Major investors, including Norges Bank, Durable Capital Partners, Arrowstreet Capital, AQR Capital Management and Swedbank, recently established or increased positions. Institutions own approximately 88.2% of outstanding shares, suggesting substantial professional-investor participation.
• Neutral Sentiment: A related article identified Veeva as one of two potentially better investments than privately held SpaceX, which may improve investor attention but does not represent a new company-specific development. Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets
• Negative Sentiment: Insider selling: Director Thomas Schwenger sold 36,000 shares worth approximately $9.0 million, reducing his stake by 64.9%. Because the transaction occurred under a pre-arranged Rule 10b5-1 plan, it may be less concerning than discretionary selling, but it could still weigh on sentiment.

Insider Buying and Selling

In related news, insider Thomas D. Schwenger sold 36,000 shares of Veeva Systems stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the transaction, the insider owned 19,449 shares in the company, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company's stock.

Institutional Trading of Veeva Systems

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp grew its holdings in shares of Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company's stock valued at $801,267,000 after purchasing an additional 85,695 shares during the period. AQR Capital Management LLC raised its stake in Veeva Systems by 31.2% during the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company's stock worth $706,078,000 after purchasing an additional 574,164 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Veeva Systems by 12.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,728,089 shares of the technology company's stock valued at $385,761,000 after purchasing an additional 189,093 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Veeva Systems by 1.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,466,827 shares of the technology company's stock valued at $436,982,000 after purchasing an additional 18,349 shares during the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Veeva Systems by 11.4% in the 3rd quarter. Bank of America Corp DE now owns 1,419,717 shares of the technology company's stock valued at $422,948,000 after buying an additional 144,982 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source